Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Iovance Biotherapeutics (IOVA) Total Debt (2023 - 2024)

Historic Total Debt for Iovance Biotherapeutics (IOVA) over the last 5 years, with Q4 2024 value amounting to $1.0 million.

  • Iovance Biotherapeutics' Total Debt changed 0.0% to $1.0 million in Q4 2024 from the same period last year, while for Dec 2024 it was $1.0 million, marking a year-over-year change of 0.0%. This contributed to the annual value of $1.0 million for FY2024, which is 0.0% changed from last year.
  • As of Q4 2024, Iovance Biotherapeutics' Total Debt stood at $1.0 million, which was down 0.0% from $1.0 million recorded in Q1 2024.
  • Iovance Biotherapeutics' 5-year Total Debt high stood at $1.0 million for Q1 2023, and its period low was $1.0 million during Q1 2023.